RMD
ResMed Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q3 2015 | 44Q | $48 | $184 | +281% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $218 | $184 | -16% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $218 | $184 | -16% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $218 | $184 | -16% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $218 | $184 | -16% |
| Two Sigma Investments | Q2 2026(8Q snapshot) | 1Q | $202 | $184 | -9% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies | Q3 2024 | Q2 2026 | → $202 | -5% |
| Coatue Management | Q4 2024 | Q1 2025 | → $230 | +1% |
| Maverick Capital 4× in & out | Q2 2024 | Q3 2024 | → $218 | +1% |
| Tiger Global | Q1 2014 | Q1 2015 | → $58 | +48% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at RESMED INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 9, 2026 — the most recent Form 4 on file — not from today.
- Form 40000943819-26-000035Jun 9, 2026
- Form 40000943819-26-000033Jun 3, 2026
- Form 40000943819-26-000030May 11, 2026
- Form 40000943819-26-000027May 4, 2026
- Form 40000943819-26-000021Apr 9, 2026
- Form 40000943819-26-000020Apr 3, 2026
- Form 40000943819-26-000019Apr 2, 2026
- Form 40000943819-26-000016Mar 11, 2026
- Form 40000943819-26-000014Mar 5, 2026
- Form 40000943819-26-000013Mar 3, 2026
- Form 40000943819-26-000011Feb 10, 2026
- Form 40000943819-26-000010Feb 6, 2026
- Form 40000943819-26-000009Feb 6, 2026
- Form 40000943819-26-000008Feb 3, 2026
- Form 40000943819-26-000004Jan 9, 2026
Fundamentals
XBRL · ResMed Inc.Annual figures sourced directly from ResMed Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for RESMED INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportMay 1, 2026
- 8-KMaterial eventApr 30, 2026
- 8-KMaterial eventApr 30, 2026
- 10-QQuarterly reportJan 30, 2026
- 8-KMaterial eventJan 29, 2026
- 8-KMaterial eventNov 20, 2025
- 10-QQuarterly reportOct 31, 2025
- 8-KMaterial eventOct 30, 2025
- DEF 14AProxy statementOct 2, 2025
- 8-KMaterial eventAug 18, 2025
- 10-KAnnual reportAug 8, 2025
- 8-KMaterial eventAug 1, 2025
- 8-KMaterial eventJul 31, 2025
- 10-QQuarterly reportApr 24, 2025
- 8-KMaterial eventApr 23, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q2 2026 | open | $202 | $204 | +1% |
| Coatue Management | Q4 2024 | Q1 2025 | $228 | $230 | +1% |
| Citadel Advisors | Q3 2024 | open | $218 | $204 | -6% |
| D.E. Shaw | Q3 2024 | open | $218 | $204 | -6% |
| AQR Capital Management | Q3 2024 | open | $218 | $204 | -6% |
| Millennium Management | Q3 2024 | open | $218 | $204 | -6% |
| Renaissance Technologies | Q3 2024 | Q2 2026 | $213 | $202 | -5% |
| Maverick Capital | Q2 2024 | Q3 2024 | $217 | $218 | +1% |
| Maverick Capital | Q2 2023 | Q1 2024 | $226 | $177 | -22% |
| Bridgewater Associates | Q4 2020 | open | $205 | $184 | -10% |
| Bridgewater Associates | Q2 2020 | Q3 2020 | $155 | $167 | +8% |
| Maverick Capital | Q4 2019 | Q1 2020 | $137 | $167 | +22% |
| Bridgewater Associates | Q1 2019 | Q2 2019 | $93 | $105 | +14% |
| Maverick Capital | Q3 2018 | Q1 2019 | $100 | $93 | -7% |
| Bridgewater Associates | Q2 2018 | Q4 2018 | $94 | $95 | +1% |
| Bridgewater Associates | Q2 2016 | Q3 2016 | $51 | $63 | +23% |
| Bridgewater Associates | Q3 2015 | Q1 2016 | $48 | $51 | +5% |
| Tiger Global | Q1 2014 | Q1 2015 | $39 | $58 | +48% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.